https://pharmadog.xyz/news/668439 pharmadog en 2026-11-11T17:47:53.000Z MAHA backs convicted rapist Russell Brand, highlighting toxic culture within movement https://pharmadog.xyz/news/668251 pharmadog en 2026-11-11T16:20:46.000Z FDA issues warning letters to two Chinese API makers for refusing record requests https://pharmadog.xyz/news/668291 pharmadog en 2026-11-11T16:11:00.000Z Study warns German drug price hikes could raise US Medicaid spending by $300 million https://pharmadog.xyz/news/668103 pharmadog en 2026-11-11T16:00:00.000Z Study proposes new obesity metric that could reverse diagnoses for millions, aiming for more precise care https://pharmadog.xyz/news/668059 pharmadog en 2026-11-11T15:44:23.000Z Flagship Pioneering combines Valo Health and Montai Therapeutics into a single company https://pharmadog.xyz/news/668083 pharmadog en 2026-11-11T15:23:20.000Z PepGen stock surges as DM1 oligonucleotide PGN-EDODM1 shows record splicing correction in Phase 2 https://pharmadog.xyz/news/668104 pharmadog en 2026-11-11T15:20:23.000Z Former ER doctor argues that limiting data input can improve clinical AI tools https://pharmadog.xyz/news/667975 pharmadog en 2026-11-11T15:15:08.000Z Capricor trims 10% of workforce as FDA decision on Duchenne cell therapy approaches https://pharmadog.xyz/news/667995 pharmadog en 2026-11-11T15:07:28.000Z Senate Health Committee Schedules Vote on FDA Commissioner Nominee Heidi Overton https://pharmadog.xyz/news/667976 pharmadog en 2026-11-11T15:00:29.000Z Capricor boosts manufacturing capacity as FDA decision on DMD cell therapy looms https://pharmadog.xyz/news/667827 pharmadog en 2026-11-11T14:34:28.000Z Incoming Democratic committee chairs move to probe Trump-era most-favored-nation drug pricing deals https://pharmadog.xyz/news/667783 pharmadog en 2026-11-11T14:00:48.000Z Beeline Medicines reports promising Phase 2 results for lupus using repurposed Bristol Myers drug https://pharmadog.xyz/news/667615 pharmadog en 2026-11-11T13:52:49.000Z UK science minister urges life-science firms to boost domestic investment as government raises medicine spending https://pharmadog.xyz/news/667847 pharmadog en 2026-11-11T13:42:00.000Z AstraZeneca acquires Omniose to boost conjugate vaccine platform as FDA flags vision-loss risk for GLP-1 drugs https://pharmadog.xyz/news/134233 pharmadog en 2026-11-11T13:22:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/667447 pharmadog en 2026-11-11T13:00:05.000Z VectorY Therapeutics raises $83.5M Series A to develop brain-targeted antibody gene therapy https://pharmadog.xyz/news/667491 pharmadog en 2026-11-11T12:56:13.000Z U.S. faces possible loss of measles elimination status as WHO panel convenes https://pharmadog.xyz/news/123087 pharmadog en 2026-11-11T12:22:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/667279 pharmadog en 2026-11-11T11:57:06.000Z Merck KGaA receives FDA approval for Abbisko-licensed joint tumor therapy https://pharmadog.xyz/news/667136 pharmadog en 2026-11-11T10:44:50.000Z Novartis' Zolgensma linked to tumors as FDA probes gene therapy and orders GLP-1 eye risk warnings https://pharmadog.xyz/news/666989 pharmadog en 2026-11-11T09:30:00.000Z Health-care providers sue employers over out-of-network medical bills https://pharmadog.xyz/news/666990 pharmadog en 2026-11-11T09:30:00.000Z Rising food costs and aid cuts leave low-income parents unable to risk nutritious meals for picky eaters https://pharmadog.xyz/news/666988 pharmadog en 2026-11-11T09:30:00.000Z Federal panel overseeing preventive care receives blanket ethics waivers despite members' pharma and practice conflicts https://pharmadog.xyz/news/666987 pharmadog en 2026-11-11T09:30:00.000Z MDCalc unveils CrossCover to boost clinician confidence in AI chatbot answers while protecting privacy https://pharmadog.xyz/news/667758 pharmadog en 2026-11-11T09:18:00.000Z Flagship-backed Valo Health merges with Montai Therapeutics to boost AI-driven drug pipeline https://pharmadog.xyz/news/667590 pharmadog en 2026-11-11T07:49:00.000Z BioNTech spends $205 million on FDA priority review voucher to accelerate oncology pipeline https://pharmadog.xyz/news/666188 pharmadog en 2026-11-11T05:37:00.000Z China’s five-year plan positions it to become a global leader in innovative biopharma by 2030 https://pharmadog.xyz/news/666189 pharmadog en 2026-11-11T05:27:00.000Z US biotech faces growth slowdown as China’s coordinated investment threatens industry https://pharmadog.xyz/news/667086 pharmadog en 2026-11-11T04:49:00.000Z Capricor cuts 10% of staff as it readies FDA decision on DMD cell therapy, NextCure trims workforce ahead of merger https://pharmadog.xyz/news/667591 pharmadog en 2026-11-11T04:47:00.000Z Amgen builds Sjögren’s case with detailed phase 3 data ahead of Novartis showdown https://pharmadog.xyz/news/666306 pharmadog en 2026-11-11T01:25:00.000Z Abbott nabs FDA approval, CE Mark for implantable cardioverter-defibrillator lead https://pharmadog.xyz/news/665111 pharmadog en 2026-11-10T23:55:00.000Z Democratic committee chairs send letters to 27 drugmakers demanding details on Trump-era MFN pricing agreements https://pharmadog.xyz/news/664899 pharmadog en 2026-11-10T22:06:43.000Z HHS Secretary RFK Jr. stays optimistic about Make America Healthy Again initiative despite midterm setbacks https://pharmadog.xyz/news/664607 pharmadog en 2026-11-10T20:05:20.000Z Senators Wyden and Sanders unite on push to lower Medicare eligibility age by a decade https://pharmadog.xyz/news/664307 pharmadog en 2026-11-10T19:31:21.000Z Mirum readies FDA filing after positive Phase 3 results for hepatitis D therapy https://pharmadog.xyz/news/664331 pharmadog en 2026-11-10T19:06:56.000Z FDA's new rare-disease framework faces first test with Capricor's Duchenne therapy decision https://pharmadog.xyz/news/664183 pharmadog en 2026-11-10T18:04:30.000Z Former Eli Lilly sales rep sues, alleging termination after raising concerns over off-label promotion of Mounjaro for weight loss https://pharmadog.xyz/news/664015 pharmadog en 2026-11-10T17:18:42.000Z Men turn to chatbots for therapy as earnings season unfolds https://pharmadog.xyz/news/663971 pharmadog en 2026-11-10T17:17:29.000Z Democrats demand unredacted drug pricing agreements from pharma firms after midterm victories https://pharmadog.xyz/news/664035 pharmadog en 2026-11-10T17:06:00.000Z Beam Therapeutics reports successful pivotal trial of base editing sickle cell therapy https://pharmadog.xyz/news/663803 pharmadog en 2026-11-10T16:23:21.000Z Beam Therapeutics' base-edited sickle cell therapy shows success in Phase 1/2 trial https://pharmadog.xyz/news/663827 pharmadog en 2026-11-10T16:10:45.000Z Coherus trims workforce by 30% as Gyre Therapeutics also cuts staff after acquisition https://pharmadog.xyz/news/663804 pharmadog en 2026-11-10T16:09:58.000Z PepGen reports positive Phase 2 data for PGN-EDODM1 in myotonic dystrophy https://pharmadog.xyz/news/663659 pharmadog en 2026-11-10T15:52:33.000Z BIO urges US to create White House biotech office and streamline trials to stay ahead of China https://pharmadog.xyz/news/663635 pharmadog en 2026-11-10T15:46:44.000Z Employers and consumers poised to reshape healthcare, says Health Tech Day discussion https://pharmadog.xyz/news/663636 pharmadog en 2026-11-10T15:34:19.000Z White House pushes Heidi Overton nomination for FDA commissioner as confirmation window narrows https://pharmadog.xyz/news/663660 pharmadog en 2026-11-10T15:23:08.000Z Beam Therapeutics' base-edited risto-cel shows 12-month pain-crisis freedom in sickle cell trial, paving way for FDA filing https://pharmadog.xyz/news/664875 pharmadog en 2026-11-10T15:11:00.000Z Oura to buy AI virtual care firm Counsel Health for $625 million, expanding in-app health services https://pharmadog.xyz/news/663661 pharmadog en 2026-11-10T15:04:56.000Z Bayer's Sunharbo becomes first FDA-approved factor XIa inhibitor blood thinner https://pharmadog.xyz/news/663491 pharmadog en 2026-11-10T14:26:23.000Z Delix raises $100M to advance at-home psychedelic without hallucinatory effects https://pharmadog.xyz/news/663512 pharmadog en 2026-11-10T14:25:24.000Z FDA approves Bayer's Sunharbo, a new class drug to lower stroke recurrence https://pharmadog.xyz/news/663467 pharmadog en 2026-11-10T14:08:44.000Z OpenAI’s health chief envisions ChatGPT Health moving patients from answers to actionable steps https://pharmadog.xyz/news/663343 pharmadog en 2026-11-10T13:38:35.000Z Dutch regulators probe Biogen over exclusive MS test for Tysabri patients https://pharmadog.xyz/news/664538 pharmadog en 2026-11-10T13:34:00.000Z Beam Therapeutics reports year-long reduction in sickle cell crises in phase 1/2 risto-cel study https://pharmadog.xyz/news/663323 pharmadog en 2026-11-10T13:23:18.000Z Altimmune to discuss Phase 3 design for alcohol use disorder drug with FDA https://pharmadog.xyz/news/663344 pharmadog en 2026-11-10T13:00:00.000Z Pharma access plans rise to 69% of late-stage drugs but gaps remain for non-communicable diseases https://pharmadog.xyz/news/663175 pharmadog en 2026-11-10T12:49:35.000Z Flu season this year appears to be affecting teens and young adults more severely, experts say https://pharmadog.xyz/news/668379 pharmadog en 2026-11-10T12:44:00.000Z Start Center for Cancer Research launches Italy’s first early-phase oncology trial site with IFO https://pharmadog.xyz/news/663067 pharmadog en 2026-11-10T12:05:00.000Z PepGen reports promising early results for myotonic dystrophy type 1 drug in six-patient trial https://pharmadog.xyz/news/663610 pharmadog en 2026-11-10T10:22:00.000Z PepGen's Phase 2 DM1 Data Show 46% Average Splicing Correction, Shares Jump 163% https://pharmadog.xyz/news/663611 pharmadog en 2026-11-10T10:17:00.000Z AstraZeneca acquires Omniose to boost bacterial vaccine capabilities https://pharmadog.xyz/news/663613 pharmadog en 2026-11-10T09:36:00.000Z Mirum's hepatitis D antibody brelovitug meets primary endpoint in phase 3 trial https://pharmadog.xyz/news/662732 pharmadog en 2026-11-10T09:30:00.000Z Experts warn AI health advice may be accurate yet lead to poorer outcomes https://pharmadog.xyz/news/662731 pharmadog en 2026-11-10T09:30:00.000Z Democratic wins in Texas, Georgia and Wisconsin could open Medicaid expansion for over a million residents https://pharmadog.xyz/news/662733 pharmadog en 2026-11-10T09:30:00.000Z BIO chief warns US biotech must act now to stay ahead of China’s new five-year plan https://pharmadog.xyz/news/662203 pharmadog en 2026-11-10T07:00:29.000Z London startup Oyster Therapeutics raises $60M to develop oral tau degraders for Alzheimer’s https://pharmadog.xyz/news/662099 pharmadog en 2026-11-10T07:00:00.000Z London biotech Oyster raises $60 million to develop tau-targeting protein degraders https://pharmadog.xyz/news/662662 pharmadog en 2026-11-10T05:07:00.000Z AbCellera halts development of OX40 antibody ABCL575 after phase-1 trial https://pharmadog.xyz/news/661931 pharmadog en 2026-11-10T05:01:00.000Z BIO proposes seven-point plan to keep US biotech ahead of China https://pharmadog.xyz/news/664242 pharmadog en 2026-11-10T05:00:00.000Z FDA issues early alert as Arrow International recalls guidewires with spring wire guide components https://pharmadog.xyz/news/664498 pharmadog en 2026-11-10T05:00:00.000Z Intersurgical pulls 22mm smoothbore breathing tubes after FDA warns of detaching connectors https://pharmadog.xyz/news/661891 pharmadog en 2026-11-10T05:00:00.000Z Amneal and BridgeBio top BioSpace 2027 Best Places to Work list https://pharmadog.xyz/news/665190 pharmadog en 2026-11-10T05:00:00.000Z Laub’s Feeding & Cubing voluntarily recalls 89 tons of mini hay cubes over botulism risk https://pharmadog.xyz/news/665036 pharmadog en 2026-11-10T05:00:00.000Z Family Farmstead Dairy recalls all cheddar cheese over possible Listeria contamination https://pharmadog.xyz/news/662514 pharmadog en 2026-11-10T03:52:00.000Z Coherus Oncology cuts 30% of staff to focus on esophageal cancer combo https://pharmadog.xyz/news/663955 pharmadog en 2026-11-10T03:20:00.000Z Deerfield Management teams with AWS to boost AI-driven life-science ventures https://pharmadog.xyz/news/663952 pharmadog en 2026-11-10T02:53:00.000Z Novocure's Optune Mya device denied FDA approval over efficacy concerns https://pharmadog.xyz/news/660963 pharmadog en 2026-11-10T00:50:50.000Z Ionis shares tumble over $1 billion as Tryngolza sales forecast cut in half https://pharmadog.xyz/news/660919 pharmadog en 2026-11-10T00:12:58.000Z Bayer's asundexian receives FDA approval for stroke prevention https://pharmadog.xyz/news/664973 pharmadog en 2026-11-10T00:00:00.000Z Experts urge pharma firms to build regulatory intelligence before laws take effect https://pharmadog.xyz/news/664974 pharmadog en 2026-11-10T00:00:00.000Z Acting FDA commissioner reports strong public interest in new expedited IND pilot https://pharmadog.xyz/news/660647 pharmadog en 2026-11-09T22:40:00.000Z Bayer's Sunharbo receives FDA approval as first Factor XIa blood thinner https://pharmadog.xyz/news/660627 pharmadog en 2026-11-09T22:28:43.000Z FDA approves Bayer’s Sunharbo, first Factor XIa inhibitor to lower stroke recurrence risk https://pharmadog.xyz/news/660834 pharmadog en 2026-11-09T22:15:46.000Z FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk https://pharmadog.xyz/news/660139 pharmadog en 2026-11-09T20:40:03.000Z ARPA-H teams meet FDA within two months of launching autonomous clinical AI program https://pharmadog.xyz/news/660140 pharmadog en 2026-11-09T20:00:21.000Z Trump's MFN drug pricing agreements complicate new drug launches https://pharmadog.xyz/news/659971 pharmadog en 2026-11-09T19:55:30.000Z FDA requires GLP-1 drug labels to include warning about rare eye disease